litlas
ログインアカウント作成

Emanuele Zucca

1990–2025 年に発表

161
論文数
37,635
被引用数
95
h 指数
157
i10 指数

被引用数

Emanuele Zucca の年別被引用数1991 年: 被引用 6 件1992 年: 被引用 3 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 7 件1996 年: 被引用 13 件1997 年: 被引用 26 件1998 年: 被引用 23 件1999 年: 被引用 16 件2000 年: 被引用 35 件2001 年: 被引用 49 件2002 年: 被引用 37 件2003 年: 被引用 58 件2004 年: 被引用 47 件2005 年: 被引用 107 件2006 年: 被引用 142 件2007 年: 被引用 109 件2008 年: 被引用 143 件2009 年: 被引用 148 件2010 年: 被引用 168 件2011 年: 被引用 170 件2012 年: 被引用 168 件2013 年: 被引用 196 件2014 年: 被引用 190 件2015 年: 被引用 208 件2016 年: 被引用 256 件2017 年: 被引用 286 件2018 年: 被引用 251 件2019 年: 被引用 973 件2020 年: 被引用 997 件2021 年: 被引用 981 件2022 年: 被引用 835 件2023 年: 被引用 677 件2024 年: 被引用 1,073 件2025 年: 被引用 479 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,698 件、この内訳の 22.1%イタリア: 引用元論文 927 件、この内訳の 7.6%ドイツ: 引用元論文 837 件、この内訳の 6.9%フランス: 引用元論文 818 件、この内訳の 6.7%イギリス: 引用元論文 807 件、この内訳の 6.6%中国: 引用元論文 757 件、この内訳の 6.2%スイス: 引用元論文 547 件、この内訳の 4.5%スペイン: 引用元論文 523 件、この内訳の 4.3%カナダ: 引用元論文 450 件、この内訳の 3.7%オランダ: 引用元論文 381 件、この内訳の 3.1%オーストラリア: 引用元論文 360 件、この内訳の 2.9%日本: 引用元論文 297 件、この内訳の 2.4%
0%22.1%その他 23%

機関

分野

  • Medicine82.3%
  • Biochemistry, Genetics and Molecular Biology14%
  • Immunology and Microbiology2.2%
  • Computer Science0.4%
  • Mathematics0.3%
  • Engineering0.2%
  • その他0.6%

トピック

  • Lymphoma Diagnosis and Treatment21.5%
  • CNS Lymphoma Diagnosis and Treatment7.5%
  • Chronic Lymphocytic Leukemia Research5.9%
  • CAR-T cell therapy research5.5%
  • Viral-associated cancers and disorders5.1%
  • Cutaneous lymphoproliferative disorders research2.9%
  • その他51.6%

共著者

全論文

検索で開く
  1. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    著者: Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz, Emanuele Zucca, Tim Lister - Journal of Clinical Oncology 2014 被引用: 5,552

  2. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: Elı́as Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Doǧan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesús F. San Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana H. Advani, Stephen M. Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  3. Revised Response Criteria for Malignant Lymphoma

    著者: Bruce D. Cheson, Beate Pfistner, Malik E. Juweid, Randy D. Gascoyne, Lena Specht, Sandra J. Horning, Bertrand Coiffier, Richard I. Fisher, Anton Hagenbeek, Emanuele Zucca, Steven T. Rosen, Sigrid Stroobants, T. Andrew Lister, Richard T. Hoppe, Martin Dreyling, Kensei Tobinai, Julie M. Vose, Joseph M. Connors, Massimo Federico, Volker Diehl - Journal of Clinical Oncology 2007 被引用: 4,448

  4. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

    著者: Sally F. Barrington, N. George Mikhaeel, Lale Kostakoğlu, Michel Meignan, Martin Hutchings, Stefan Müeller, Lawrence H. Schwartz, Emanuele Zucca, Richard I. Fisher, Judith Trotman, Otto S. Hoekstra, Rodney J. Hicks, Michael O’Doherty, Roland Hustinx, Alberto Biggi, Bruce D. Cheson - Journal of Clinical Oncology 2014 被引用: 1,648

  5. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    著者: Lauren E. Abrey, Tracy T. Batchelor, Andrés J.M. Ferreri, Mary Gospodarowicz, Elisa Jacobsen Pulczynski, Emanuele Zucca, Justine R. Smith, Agnieszka Korfel, Carole Soussain, Lisa M. DeAngelis, Edward A. Neuwelt, Brian Patrick O’Neill, Eckhard Thiel, Tamara Shenkier, Francesc Graus, Martin J. van den Bent, John F. Seymour, Philip Poortmans, Jamés O. Armitage, Franco Cavalli - Journal of Clinical Oncology 2005 被引用: 906

  6. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

    著者: Valeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, Maurizio Martini, Martina Di Trani, Gabriela Forestieri, Martina Manzoni, Adalgisa Condoluci, Alberto J. Arribas, Lodovico Terzi-di-Bergamo, Silvia L. Locatelli, Elisa Cupelli, Luca Ceriani, Alden A. Moccia, Anastasios Stathis, Luca Nassi, Clara Deambrogi, Fary Diop, Francesca Guidetti, Alessandra Cocomazzi, Salvatore Annunziata, Vittoria Rufini, Alessandro Giordano, Antonino Neri, Renzo Boldorini, B. Gerber, Francesco Bertoni, Michele Ghielmini, Georg Stüssi, Armando Santoro, Franco Cavalli, Emanuele Zucca, Luigi Maria Larocca, Gianluca Gaïdano, Stefan Hohaus, Carmelo Carlo‐Stella, Davide Rossi - Blood 2018 被引用: 338

  7. Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index

    著者: N. George Mikhaeel, Martijn W. Heymans, Jakoba J. Eertink, Henrica C. W. de Vet, Ronald Boellaard, Ulrich Dührsen, Luca Ceriani, Christine Hanoun, Sanne E. Wiegers, Andreas Hüttmann, Pieternella J. Lugtenburg, Emanuele Zucca, Gerben J.C. Zwezerijnen, Otto S. Hoekstra, Josée M. Zijlstra, Sally F. Barrington - Journal of Clinical Oncology 2022 被引用: 149

  8. Genomic profiling for clinical decision making in lymphoid neoplasms

    著者: Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elı́as Campo, Andrew Davies, Ahmet Doǧan, Jude Fitzgibbon, Steven M. Horwitz, Ari Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverría, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 被引用: 161

  9. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

    著者: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Valter Torri, Christopher P. Fox, Paul La Rosée, Elisabeth Schorb, Achille Ambrosetti, Alexander Röth, Claire Hemmaway, Angela Ferrari, Kim Linton, Roberta Rudà, Mascha Binder, Tobias Pukrop, Monica Balzarotti, Alberto Fabbri, Peter Johnson, Jette Sønderskov Gørløv, Georg Heß, Jens Panse, Francesco Pisani, Alessandra Tucci, Stephan Stilgenbauer, Bernd Hertenstein, Ulrich Keller, Stefan W. Krause, Alessandro Levis, Hans‐Joachim Schmoll, Franco Cavalli, Jürgen Finke, Michele Reni, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2016 被引用: 599

  10. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    著者: Sandy Amorim, Anastasios Stathis, Mary Gleeson, Sunil Iyengar, Valeria Magarotto, Xavier Leleu, Franck Morschhauser, Lionel Karlin, Florence Broussais, Keyvan Rezaï, Patrice Herait, Carmen Kahatt, François Lokiec, Gilles Salles, Thierry Façon, Antonio Palumbo, David Cunningham, Emanuele Zucca, Catherine Thiéblemont - The Lancet Haematology 2016 被引用: 428

  11. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

    著者: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Christopher P. Fox, Elisabeth Schorb, Claudia Celico, Monica Falautano, Alessandro Nonis, Paul La Rosée, Mascha Binder, Alberto Fabbri, Fiorella Ilariucci, Mauro Krampera, Alexander Röth, Claire Hemmaway, Peter Johnson, Kim Linton, Tobias Pukrop, Jettes Sønderskov Gørløv, Monica Balzarotti, Georg Heß, Ulrich Keller, Stephan Stilgenbauer, Jense Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Manuela Zanni, Stefan W. Krause, Hans‐Joachim Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, IELSG32 study investigators - Leukemia 2022 被引用: 162

  12. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    著者: Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, Christopher P. Fox, Elisabeth Schorb, Paul La Rosée, Mascha Binder, Alberto Fabbri, Valter Torri, Eleonora Minacapelli, Monica Falautano, Fiorella Ilariucci, Achille Ambrosetti, Alexander Röth, Claire Hemmaway, Peter Johnson, Kim Linton, Tobias Pukrop, Jette Sønderskov Gørløv, Monica Balzarotti, Georg Heß, Ulrich Keller, Stephan Stilgenbauer, Jens Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Alessandro Levis, Stefan W. Krause, Hans‐Joachim Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Michael Pfreundschuh, Giuseppina Cabras, F. Angrilli, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Michele Reni, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2017 被引用: 381

  13. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    著者: Andrés J.M. Ferreri, Jean‐Yves Blay, Michele Reni, Felice Pasini, Michele Spina, Achille Ambrosetti, Antonello Calderoni, Andrea Rossi, V. Vavassori, Annarita Conconi, Liliana Devizzi, Françoise Berger, Maurilio Ponzoni, Bettina Borisch, Marianne Tinguely, Michele Cerati, Mario Milani, Enrico Orvieto, Juvenal Sánchez, Christine Chevreau, Stefania Dell’Oro, Emanuele Zucca, Franco Cavalli - Journal of Clinical Oncology 2003 被引用: 840

  14. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Emanuele Zucca, Luca Arcaini, Christian Buske, Peter Johnson, Maurilio Ponzoni, Markus Raderer, Umberto Ricardi, Antonio Salar, Κώστας Σταματόπουλος, Catherine Thiéblemont, Andrew Wotherspoon, Marco Ladetto - Annals of Oncology 2020 被引用: 341

  15. Marginal zone lymphomas

    著者: Emanuele Zucca, Davide Rossi, Francesco Bertoni - Hematological Oncology 2022 被引用: 153

  16. Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

    著者: Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Chiara Tarantelli, Federica Melle, Giovanna Motta, Valdemar Priebe, Andrea Rinaldi, Gaetanina Golino, Afua A. Mensah, Luca Aresu, Emanuele Zucca, Stefano Pileri, Michael Witcher, B. Brown, Claes Wahlestedt, Francis J. Giles, Anastasios Stathis, Francesco Bertoni - Blood Advances 2020 被引用: 73

  17. The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

    著者: Michela Boi, Eugenio Gaudio, Paola Bonetti, Ivo Kwee, Elena Bernasconi, Chiara Tarantelli, Andrea Rinaldi, Monica Testoni, Luciano Cascione, Maurilio Ponzoni, Afua A. Mensah, Anastasios Stathis, Georg Stüssi, María E. Riveiro, Patrice Herait, Giorgio Inghirami, Esteban Cvitkovic, Emanuele Zucca, Francesco Bertoni - Clinical Cancer Research 2015 被引用: 283

  18. An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

    著者: Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Bart M. de Vries, Pieternella J. Lugtenburg, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Simone Pieplenbosch, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Henrica C. W. de Vet, PETRA, Otto S. Hoekstra, Coreline N. Burggraaff, Annelies Bes, Martijn W. Heymans, Yvonne W. S. Jauw, Martine E.D. Chamuleau, Sally F. Barrington, G. Mikhaeel, Emanuele Zucca, Luca Ceriani, Robert Carr, Tamás Györke, Sándor Czibor, Stefano Fanti, Lale Kostakoğlu, Annika Loft, Martin Hutchings, Sze Ting Lee, Josée M. Zijlstra, Ronald Boellaard - Scientific Reports 2023 被引用: 34

  19. Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    著者: Anastasios Stathis, Emanuele Zucca, Mohamed Békradda, Carlos Gomez‐Roca, Jean‐Pierre Delord, Thibault De La Motte Rouge, Emmanuelle Uro‐Coste, Filippo de Braud, Giuseppe Pelosi, Christopher A. French - Cancer Discovery 2016 被引用: 381

  20. Epidemiology of hematological malignancies

    著者: Delvys Rodríguez‐Abreu, Andrea Bordoni, Emanuele Zucca - Annals of Oncology 2007 被引用: 297

  21. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

    著者: Ekaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Paola M. V. Rancoita, Jonathan C. Strefford, David Oscier, Κώστας Σταματόπουλος, Theodora Papadaki, Françoise Berger, Ken H. Young, Fiona Murray, Richard Rosenquist, Timothy C. Greiner, Wing C. Chan, Ester Orlandi, Marco Lucioni, Roberto Marasca, Giorgio Inghirami, Marco Ladetto, Francesco Forconi, Sergio Cogliatti, Hana Votavová, Steven H. Swerdlow, Stephan Stilgenbauer, Miguel Á. Piris, András Matolcsy, Dominic V. Spagnolo, Eugene Nikitin, Alberto Zamò, Valter Gattei, Govind Bhagat, German Ott, Emanuele Zucca, Gianluca Gaïdano, Francesco Bertoni - Blood 2013 被引用: 249

  22. MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

    著者: Andrés J.M. Ferreri, Jeanette K. Doorduijn, Alessandro Re, Maria Giuseppina Cabras, Jeffery Smith, Fiorella Ilariucci, Mario Luppi, Teresa Calimeri, Chiara Cattaneo, Jahanzaib Khwaja, Barbara Botto, Claudia Cellini, Luca Nassi, Kim Linton, Pam McKay, Jacopo Olivieri, Caterina Patti, Francesca Re, Alessandro Fanni, Vikram Singh, Jacoline E. C. Bromberg, Kelly Cozens, Elisabetta Gastaldi, Massimo Bernardi, Nicola Cascavilla, Andrew Davies, Christopher P. Fox, Maurizio Frezzato, Wendy Osborne, Anna Marina Liberati, Urban Novak, Renato Zambello, Emanuele Zucca, Kate Cwynarski - The Lancet Haematology 2021 被引用: 104

  23. Genetic and phenotypic attributes of splenic marginal zone lymphoma

    著者: Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Faderl, Valeria Spina, Adalgisa Condoluci, L. Bonomini, Gabriela Forestieri, Ricardo Koch, Deborah Piffaretti, Katia Pini, Maria Cristina Pirosa, Micol Giulia Cittone, Alberto J. Arribas, Marco Lucioni, Guido Ghilardi, Wei Wu, Luca Arcaini, Maria João Baptista, Gabriela Bastidas, Sı́lvia Beà, Renzo Boldorini, Alessandro Broccoli, Marco Buehler, Vincenzo Canzonieri, Luciano Cascione, Luca Ceriani, Sergio Cogliatti, Paolo Corradini, Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaïdano, Juan F. Garcı́a, B. Gerber, Paolo Ghia, María Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Inghirami, Marco Ladetto, Armando López‐Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A. Moccia, Manuela Mollejo, Carlos Montalbán, Urban Novak, David Oscier, Francesco Passamonti, Francesco Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Salles, Elisa Santambrogio, Lydia Scarfò, Anastasios Stathis, Georg Stüssi, Julia T. Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thiéblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elı́as Campo, Laurence de Leval, Stefan Dirnhofer, Stefano Pileri, Miguel Á. Piris, Alexandra Traverse‐Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi - Blood 2021 被引用: 97

  24. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

    著者: Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, Vittoria Tarantino, Martina Manni, Clémentine Sarkozy, Sara Alonso, Mariëlle J. Wondergem, Guillaume Cartron, Armando López‐Guillermo, Djamila E. Issa, Franck Morschhauser, Miguel Alcoceba, Eva Kimby, Chiara Rusconi, Martine E.D. Chamuleau, Harald Holte, Sandra Lockmer, Silvia Montoto, María Gomes da Silva, Igor Aurer, Emanuele Zucca, Ewa Paszkiewicz‐Kozik, Carla Minoia, Tetiana Skrypets, Yngvild Nuvin Blaker, Gilles Salles, Bertrand Coiffier - The Lancet Haematology 2018 被引用: 116